Help
Subscribe


GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy

 27 May 2018

Advanced search
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

Mutations of inflammatory marker genes increase gastric cancer risk

A meta-analysis published in the latest British Journal of Cancer confirms the link between tumor-necrosis factor-A polymorphisms and gastric cancer risk.

News image

fiogf49gjkf04

Inflammation is one of the early phases in the development of gastric cancer.

Several studies have examined the association of polymorphisms in tumor-necrosis factor-A gene with gastric cancer risk.

Dr Kamangar and colleagues from Maryland, USA conducted a meta-analysis of reviews and summarized published evidence for these associations.

The overall odds ratios for TT genotypes for tumor-necrosis factor-A gene -857 was 1.6
British Journal of Cancer

The team searched several databases yielding 24 independent studies that reported on the associations between tumor-necrosis factor-A gene polymorphisms and gastric cancer risk.

The team analyzed available data for the most commonly investigated polymorphisms.

The team noted that 23 studies investigated tumor-necrosis factor-A gene -308G>A, 9 studied tumor-necrosis factor-A gene -238G>A, and 5 studied tumor-necrosis factor-A gene -857C>T.

The team calculated summary odds ratios and 95% confidence intervals in the random-effects model using the DerSimonian-Laird method.

The researchers calculated q-statistic and used the I2-statistic to examine heterogeneity.

Funnel plots were plotted to examine small study effects.

The overall odds ratios for AG and AA genotypes vs GG genotype for tumor-necrosis factor-A gene -308 were 1.1, and 1.5, respectively.

The team found that for tumor-necrosis factor-A gene -238, the corresponding odds ratios were 1.05, and 1.3, respectively.

The overall odds ratios for CT and TT genotypes for tumor-necrosis factor-A gene -857 were 1.1, and 1.6, respectively.

The researchers found that the statistically significant association between tumor-necrosis factor-A gene -308GG and gastric cancer was limited to western populations.

This association showed little heterogeneity, and remained consistently strong when analyses were limited to anatomic and histologic subtypes of gastric cancer.

There was little heterogeneity when the analyses were limited to studies in which genotype frequencies were in Hardy-Weinberg equilibrium, or limited to larger studies.

The researchers observed that these same subgroup analyses did not change results associated with other polymorphisms.

Dr Kamangar's team concluded, "Tumor-necrosis factor-A gene -308AA genotype was associated with a statistically significant increased risk of gastric cancer, whereas other studied polymorphisms were not."

"The association between tumor-necrosis factor-A gene -857TT genotype, and gastric cancer was near significant, and may become significant if more studies are published."

Br J Cancer 2008: 98(4): 1443-51
24 April 2008

Go to top of page Email this page Email this page to a colleague

 25 May 2018 
Technology to increase colorectal cancer screening
 25 May 2018 
Post‐operative complications in elderly IBD
 25 May 2018 
Colorectal cancer–specific mortality
 24 May 2018 
Alcohol consumption and outcomes in drug-induced liver injury
 24 May 2018 
Patient-reported outcome measures in IBD trials
 24 May 2018 
Precision medicine for tumors
 23 May 2018 
Management of perianal fistulas in Crohn’s disease
 23 May 2018 
Cardiovascular risk in diabetes mellitus with NAFLD
 23 May 2018 
High body mass index is and ulcerative colitis
 22 May 2018 
Worldwide H.pylori prevalence
 22 May 2018 
PPI and risk of stroke
 22 May 2018 
Online tool predicts bowel dysfunction severity prior to anterior resection
 21 May 2018 
PPI use and cognitive decline
 21 May 2018 
Depressive symptoms in IBD youth
 21 May 2018 
Fecal incontinence and quality of life in IBD
 18 May 2018 
Esophageal dilatation in clinical practice 
 17 May 2018 
IBD and later extraintestinal manifestations
 17 May 2018 
Repeat stool DNA testing
 17 May 2018 
IBS and chronic fatigue following GI infection
 16 May 2018 
Factors associated with fecal incontinence
 16 May 2018 
Diagnostic delay in Crohn's disease
 16 May 2018 
Cardiovascular risk in diabetes mellitus with NAFLD
 15 May 2018 
Guidelines for management of Crohn's
 15 May 2018 
New therapies for CDI
 15 May 2018 
Hep B in the Grey Zone
 14 May 2018 
Blood test for the diagnosis of fibrotic NASH
 14 May 2018 
Outcomes at bariatric centers of excellence
 14 May 2018 
Management of perianal fistulas in Crohn’s
 11 May 2018 
Detection of undiagnosed celiac disease
 11 May 2018 
Alcohol consumption and drug-induced liver injury
 10 May 2018 
Colorectal cancer screening
 10 May 2018 
Fibrosis in patients with chronic hepatitis B
 09 May 2018 
Fecal incontinence
 09 May 2018 
Health problems and IBS
 09 May 2018 
Esophageal dilatation in clinical practice 
 07 May 2018 
Omitting antibiotics in uncomplicated acute diverticulitis
 07 May 2018 
Health problems and IBS
 07 May 2018 
Assessment of diminutive colorectal polyps
 04 May 2018 
National Institutes of Health workshop and obesity
 04 May 2018 
Factors associated with fecal incontinence
 04 May 2018 
Colorectal cancer screening and ethnic inequities
 03 May 2018 
Gastrointestinal ultrasound in IBD
 03 May 2018 
Ultransonography in postsurgical recurrence in Crohn's
 02 May 2018 
Symptom assessment in cirrhotic ascites
 02 May 2018 
Hep C antiviral treatment and liver cancer risk
 02 May 2018 
Chronic Hep B
 01 May 2018 
European guidelines on pancreatic cystic neoplasms
 01 May 2018 
Interferon‐free regimens in Hep C
 01 May 2018 
Age at IBD onset and extraintestinal complications
 30 April 2018 
Formula for preterm infants
 30 April 2018 
Primary antibiotic resistance and sequential therapy for H. pylori
 27 April 2018 
Eastern and western practices for endoscopic resection of colorectal lesions
 27 April 2018 
Anxiety scale for chronic esophageal disease
 27 April 2018 
Disease activity in eosinophilic esophagitis
 26 April 2018 
Obesity and physical activity in diverticulosis
 26 April 2018 
Primary sclerosing cholangitis in the USA
 25 April 2018 
Aspirin and pancreatic cancer
 25 April 2018 
Central mediators of irinotecan-induced steatohepatitis
 25 April 2018 
Neuroimaging in Hep C
 24 April 2018 
Scoring system identifies cancer risk in Barrett's

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2018 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us